120 related articles for article (PubMed ID: 6311866)
21. Nuclear uptake of 1,25-dihydroxy[3H]cholecalciferol in dispersed fibroblasts cultured from normal human skin.
Eil C; Marx SJ
Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2562-6. PubMed ID: 6264480
[TBL] [Abstract][Full Text] [Related]
22. A novel mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor causes hereditary 1,25-dihydroxyvitamin D-resistant rickets.
Lin NU; Malloy PJ; Sakati N; al-Ashwal A; Feldman D
J Clin Endocrinol Metab; 1996 Jul; 81(7):2564-9. PubMed ID: 8675579
[TBL] [Abstract][Full Text] [Related]
23. Hereditary resistance to 1,25-dihydroxyvitamin D: clinical and radiological improvement during high-dose oral calcium therapy.
Sakati N; Woodhouse NJ; Niles N; Harfi H; de Grange DA; Marx S
Horm Res; 1986; 24(4):280-7. PubMed ID: 3023230
[TBL] [Abstract][Full Text] [Related]
24. Response to parathyroid hormone and 1,25-dihydroxyvitamin D3 of bone-derived cells isolated from normal children and children with abnormalities in skeletal development.
Silve C; Grosse B; Tau C; Garabedian M; Fritsch J; Delmas PD; Cournot-Witmer G; Balsan S
J Clin Endocrinol Metab; 1986 Mar; 62(3):583-90. PubMed ID: 3003145
[TBL] [Abstract][Full Text] [Related]
25. Does 1,25-dihydroxyvitamin D participate in the regulation of hormone release from endocrine glands?
Hochberg Z; Borochowitz Z; Benderli A; Vardi P; Oren S; Spirer Z; Heyman I; Weisman Y
J Clin Endocrinol Metab; 1985 Jan; 60(1):57-61. PubMed ID: 2981087
[TBL] [Abstract][Full Text] [Related]
26. Rapid diagnosis of vitamin D-dependent rickets type II by use of phytohemagglutinin-stimulated lymphocytes.
Takeda E; Kuroda Y; Saijo T; Toshima K; Naito E; Kobashi H; Iwakuni Y; Miyao M
Clin Chim Acta; 1986 Mar; 155(3):245-50. PubMed ID: 3011315
[TBL] [Abstract][Full Text] [Related]
27. Identification of a novel mutation in hereditary vitamin D resistant rickets causing exon skipping.
Hawa NS; Cockerill FJ; Vadher S; Hewison M; Rut AR; Pike JW; O'Riordan JL; Farrow SM
Clin Endocrinol (Oxf); 1996 Jul; 45(1):85-92. PubMed ID: 8796143
[TBL] [Abstract][Full Text] [Related]
28. Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets.
Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF; Breed AL
Pediatrics; 1983 Apr; 71(4):559-67. PubMed ID: 6300745
[TBL] [Abstract][Full Text] [Related]
29. Clinical and biochemical findings in parents of children with vitamin D-dependent rickets Type II.
Yokota I; Takeda E; Ito M; Kobashi H; Saijo T; Kuroda Y
J Inherit Metab Dis; 1991; 14(2):231-40. PubMed ID: 1653381
[TBL] [Abstract][Full Text] [Related]
30. A novel nonsense mutation in the ligand binding domain of the vitamin D receptor causes hereditary 1,25-dihydroxyvitamin D-resistant rickets.
Malloy PJ; Zhu W; Bouillon R; Feldman D
Mol Genet Metab; 2002 Dec; 77(4):314-8. PubMed ID: 12468277
[TBL] [Abstract][Full Text] [Related]
31. Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts.
Schedlich LJ; Muthukaruppan A; O'Han MK; Baxter RC
Mol Endocrinol; 2007 Oct; 21(10):2378-90. PubMed ID: 17595320
[TBL] [Abstract][Full Text] [Related]
32. Analysis of the relation between alopecia and resistance to 1,25-dihydroxyvitamin D.
Marx SJ; Bliziotes MM; Nanes M
Clin Endocrinol (Oxf); 1986 Oct; 25(4):373-81. PubMed ID: 3040300
[TBL] [Abstract][Full Text] [Related]
33. Demonstration of 1,25-dihydroxyvitamin D3 receptors in human skin biopsies.
Feldman D; Chen T; Hirst M; Colston K; Karasek M; Cone C
J Clin Endocrinol Metab; 1980 Dec; 51(6):1463-5. PubMed ID: 6255007
[TBL] [Abstract][Full Text] [Related]
34. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
35. Hereditary resistance to 1,25-dihydroxyvitamin D.
Marx SJ; Liberman UA; Eil C; Gamblin GT; DeGrange DA; Balsan S
Recent Prog Horm Res; 1984; 40():589-620. PubMed ID: 6091196
[No Abstract] [Full Text] [Related]
36. I alpha, 25-Dihydroxyvitamin D3 receptor in the X-linked hypophosphatemic mouse.
Seino Y; Sierra RI; Ichikawa M; Avioli LV
Endocrinology; 1982 Jul; 111(1):329-31. PubMed ID: 6282570
[TBL] [Abstract][Full Text] [Related]
37. [Effect of mycotoxins aflatoxin B1 and T-2 toxin on the vitamin D3 metabolism and binding of its hormonal form 1,25-dihydroxyvitamin D3 in rats].
Sergeev IN; Arkhapchev IuP; Kravchenko LV; Kodentsova VM; Piliia NM
Vopr Med Khim; 1988; 34(4):51-7. PubMed ID: 2848363
[TBL] [Abstract][Full Text] [Related]
38. Decreased nuclear uptake of 1,25-dihydroxyvitamin D3 by duodenal mucosal cells in the X-linked hypophosphatemic mouse.
Yamamoto T; Seino Y; Yamaoka K; Yabuuchi H
Endocrinology; 1985 Nov; 117(5):2252-4. PubMed ID: 2995011
[TBL] [Abstract][Full Text] [Related]
39. Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptor.
Dokoh S; Donaldson CA; Haussler MR
Cancer Res; 1984 May; 44(5):2103-9. PubMed ID: 6324995
[TBL] [Abstract][Full Text] [Related]
40. Interaction of 1,25-dihydroxyvitamin-D3 with keratinocytes and fibroblasts from skin of normal subjects and a subject with vitamin-D-dependent rickets, type II: a model for study of the mode of action of 1,25-dihydroxyvitamin D3.
Clemens TL; Adams JS; Horiuchi N; Gilchrest BA; Cho H; Tsuchiya Y; Matsuo N; Suda T; Holick MF
J Clin Endocrinol Metab; 1983 Apr; 56(4):824-30. PubMed ID: 6300167
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
